Andesa Financial Management Inc. Eli Lilly & CO Transaction History

Andesa Financial Management Inc.

$338 Million
Q1 2023

A detailed history of Andesa Financial Management Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Andesa Financial Management Inc. holds 11,154 shares of LLY stock, worth $10.1 Million. This represents 1.13% of its overall portfolio holdings.

Number of Shares

11,154

Previous 5,779 93.01%

Holding current value

$10.1 Million

Previous $2.11 Million 81.17%

% of portfolio

1.13%

Previous 1.15%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 04, 2023	BUY	$310.63 - $364.82 $1.67 Million - $1.96 Million	5,375 Added 93.01%	11,154 $3.83 Million
Q4 2022 Feb 10, 2023	SELL	$321.55 - $374.67 $1.89 Million - $2.2 Million	-5,864 Reduced 50.37%	5,779 $2.11 Million
Q3 2022 Nov 03, 2022	BUY	$296.48 - $337.87 $1.7 Million - $1.94 Million	5,748 Added 97.51%	11,643 $3.77 Million
Q2 2022 Jul 27, 2022	SELL	$278.73 - $327.27 $9,755 - $11,454	-35 Reduced 0.59%	5,895 $1.91 Million
Q1 2022 May 09, 2022	SELL	$234.69 - $291.66 $8,448 - $10,499	-36 Reduced 0.6%	5,930 $1.7 Million
Q4 2021 Jan 27, 2022	SELL	$224.85 - $279.04 $4,946 - $6,138	-22 Reduced 0.37%	5,966 $1.65 Million
Q3 2021 Oct 13, 2021	SELL	$221.6 - $272.71 $1.5 Million - $1.84 Million	-6,756 Reduced 53.01%	5,988 $1.38 Million
Q2 2021 Aug 10, 2021	SELL	$180.55 - $233.54 $63,553 - $82,206	-352 Reduced 2.69%	12,744 $2.93 Million
Q1 2021 Apr 20, 2021	BUY	$164.32 - $212.72 $799,416 - $1.03 Million	4,865 Added 59.11%	13,096 $2.45 Million
Q4 2020 Feb 11, 2021	SELL	$130.46 - $172.63 $738,794 - $977,603	-5,663 Reduced 40.76%	8,231 $1.39 Million
Q3 2020 Nov 09, 2020	BUY	$146.22 - $169.13 $847,491 - $980,277	5,796 Added 71.57%	13,894 $2.06 Million
Q2 2020 Aug 07, 2020	SELL	$136.42 - $164.18 $32,195 - $38,746	-236 Reduced 2.83%	8,098 $1.33 Million
Q1 2020 Apr 21, 2020	BUY	$119.05 - $147.35 $107,978 - $133,646	907 Added 12.21%	8,334 $1.16 Million
Q4 2019 Jan 31, 2020	BUY	$106.92 - $132.43 $5,452 - $6,753	51 Added 0.69%	7,427 $974,000
Q3 2019 Nov 08, 2019	BUY	$106.79 - $116.16 $171,718 - $186,785	1,608 Added 27.88%	7,376 $823,000
Q2 2019 Jul 30, 2019	SELL	$110.79 - $129.32 $645,684 - $753,676	-5,828 Reduced 50.26%	5,768 $638,000
Q1 2019 May 02, 2019	BUY	$111.31 - $131.02 $646,043 - $760,440	5,804 Added 100.21%	11,596 $1.51 Million
Q4 2018 Jan 24, 2019	BUY	$105.9 - $118.64 $23,509 - $26,338	222 Added 3.99%	5,792 $670,000
Q4 2017 Sep 18, 2018	BUY	$81.94 - $87.89 $456,405 - $489,547	5,570	5,570 $470,000

Others Institutions Holding LLY

# of Institutions

3,901

Shares Held

765M

Call Options Held

6.35M

Put Options Held

7.97M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $859B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Andesa Financial Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Andesa Financial Management Inc. with notifications on news.

Account

Andesa Financial Management Inc. Eli Lilly & CO Transaction History